Generics - Financial, Biotechnology

Filter

Current filters:

FinancialBiotechnology

Popular Filters

Pharma associations strongly support Senate bill on FDA User Fees sequestration exemptions

05-08-2013

In the USA last week, Mark Pryor (Democrat, Arkansas), chairman of the Senate Appropriations Subcommittee…

BiotechnologyFinancialGenericsLegalNorth AmericaPharmaceuticalPolitics

Increased focus on generics and biosimilars only way to make European health care sustainable, says EGA

13-06-2013

Addressing delegates at the 19th European Generic medicines Association (EGA) Annual Conference in Athens,…

BiotechnologyEuropeFinancialGenericsHealthcareRegulation

EMA 2013 work program and budget endorsed by management board

18-12-2012

The European Medicines Agency's Management Board revealed yesterday that, at its meeting on December…

BiotechnologyEuropeFinancialGenericsPharmaceuticalRegulation

Medicines for normal aging conditions overtakes costs of treating most chronic diseases; Express Scripts

30-10-2012

In the USA, prescription-drug treatment regimens for conditions that are a normal part of aging are now…

BiotechnologyFinancialGenericsHealthcareNorth AmericaPharmaceutical

News briefs: Genmab/GSK, Gilead and Mylan

24-05-2012

Denmark's Genmab (OMX: GEN) yesterday received a milestone payment of 20 million Danish kroner ($3.4…

Anti-viralsBiotechnologycobicistatFinancialGenericsGenmabGilead SciencesGlaxoSmithKlineMylan LaboratoriesOncologyRegulationViramune

FDA completes work on three drug user fee programs

16-01-2012

The US Food and Drug Administration has completed its recommendations for three user fee programs that…

BiotechnologyFinancialGenericsNorth AmericaPharmaceuticalRegulation

European Medicines Agency’s 2012 work program and budget

18-12-2011

The European Medicines Agency’s Management Board, at its meeting on 15 December 15, adopted the…

BiotechnologyEuropeFinancialGenericsPharmaceuticalRegulationResearch

FDA plans biosimilars user fee talks

08-12-2011

The US Food and Drug Administration has published a Federal Register notice announcing a December 16…

BiotechnologyFinancialGenericsNorth AmericaRegulation

Back to top